Abstract
We describe an outbreak of a carbapenemase-producing Klebsiella pneumoniae sequence type 258 (ST258) clone in an Italian hospital during two months in 2010. The rapid detection and management of the eleven patients colonized and infected with KPC-producing K.pneumoniae curbed the spread of this multidrug-resistant organism.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
Bacterial Proteins
-
Carbapenems / therapeutic use*
-
Containment of Biohazards
-
Cross Infection / drug therapy*
-
Cross Infection / epidemiology
-
Cross Infection / microbiology
-
Cross Infection / prevention & control
-
Disease Outbreaks
-
Drug Resistance, Bacterial*
-
Hospitals
-
Humans
-
Infection Control
-
Italy / epidemiology
-
Klebsiella Infections / drug therapy*
-
Klebsiella Infections / epidemiology
-
Klebsiella Infections / microbiology
-
Klebsiella Infections / prevention & control
-
Klebsiella pneumoniae / drug effects*
-
Klebsiella pneumoniae / genetics
-
Klebsiella pneumoniae / isolation & purification
-
beta-Lactamases
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Carbapenems
-
beta-Lactamases
-
carbapenemase